Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Sleep Disorders

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 56 articles:
HTML format



Single Articles


    March 2024
  1. CHENG WJ, Finnsson E, Agustsson JS, Sands SA, et al
    Endotypic traits of supine position and supine-predominant obstructive sleep apnoea in Asian patients.
    Eur Respir J. 2024;63:2301660.
    PubMed     Abstract available


    February 2024
  2. PEPIN JL, Tamisier R, Benjafield AV, Rinder P, et al
    CPAP resumption after a first termination and impact on all-cause mortality in France.
    Eur Respir J. 2024;63:2301171.
    PubMed     Abstract available


    December 2023
  3. PEPIN JL, Randerath W
    Continuous positive airway pressure for prevention of cardiovascular events and mortality: why evidence is evolving.
    Eur Respir J. 2023;62:2301741.
    PubMed    


  4. PINILLA L, Esmaeili N, Labarca G, Martinez-Garcia MA, et al
    Hypoxic burden to guide CPAP treatment allocation in patients with obstructive sleep apnoea: a post hoc study of the ISAACC trial.
    Eur Respir J. 2023;62:2300828.
    PubMed     Abstract available


    July 2023
  5. GOTTLIEB DJ
    CPAP therapy for obstructive sleep apnoea: are the right questions being asked?
    Eur Respir J. 2023;62:2300575.
    PubMed    


  6. MCNICHOLAS WT, Arnardottir ES, Leppanen T, Schiza S, et al
    CPAP therapy for obstructive sleep apnoea: persisting challenges in outcome assessment.
    Eur Respir J. 2023;62:2300182.
    PubMed    


    April 2023
  7. JAFFUEL D, Mallet JP, Roubille F, Bourdin A, et al
    Muscle sympathetic nerve activity and adaptive servo-ventilation: questions remain.
    Eur Respir J. 2023;61:2300002.
    PubMed    


  8. TAMISIER R, Pepin JL, Levy P
    Reply to: Muscle sympathetic nerve activity and adaptive servo-ventilation: questions remain.
    Eur Respir J. 2023;61:2300247.
    PubMed    


  9. SABIL A, Gagnadoux F
    Obstructive sleep apnoea, nocturnal hypoxaemia, and cognitive decline in elderly patients.
    Eur Respir J. 2023;61:2300300.
    PubMed    


  10. MARCHI NA, Solelhac G, Berger M, Haba-Rubio J, et al
    Obstructive sleep apnoea and 5-year cognitive decline in the elderly.
    Eur Respir J. 2023;61:2201621.
    PubMed     Abstract available


    March 2023
  11. MATEIKA JH
    Respiratory effort and hypertension in obstructive sleep apnoea.
    Eur Respir J. 2023;61:2202421.
    PubMed    


  12. DIAZ-GARCIA E, Sanz-Rubio D, Garcia-Tovar S, Alfaro E, et al
    Inflammasome activation mediated by oxidised low-density lipoprotein in patients with sleep apnoea and early subclinical atherosclerosis.
    Eur Respir J. 2023;61:2201401.
    PubMed     Abstract available


  13. MARTINOT JB, Le-Dong NN, Malhotra A, Pepin JL, et al
    Respiratory effort during sleep and prevalent hypertension in obstructive sleep apnoea.
    Eur Respir J. 2023;61:2201486.
    PubMed     Abstract available


  14. TAMISIER R, Pepin JL, Levy P
    Reply to: Central apnoeas, sympathetic activation and mortality in heart failure: look before you leap.
    Eur Respir J. 2023;61:2300042.
    PubMed    


  15. BORRELLI C, Spiesshoefer J, Macefield V, Giannoni A, et al
    Central apnoeas, sympathetic activation and mortality in heart failure: look before you leap.
    Eur Respir J. 2023;61:2202197.
    PubMed    


    February 2023
  16. CUBILLOS-ZAPATA C, Martinez-Garcia MA, Diaz-Garcia E, Garcia-Tovar S, et al
    Obstructive sleep apnoea is related to melanoma aggressiveness through paraspeckle protein-1 upregulation.
    Eur Respir J. 2023;61:2200707.
    PubMed     Abstract available


  17. BONSIGNORE MR, La Rovere MT
    Sympathetic activation in patients with heart failure and central sleep apnoea: is it friend or foe?
    Eur Respir J. 2023;61:2202170.
    PubMed    


  18. SANCHEZ-DE-LA-TORRE M, Barbe F
    Cellular heterogeneity insights and molecular signatures in paediatric sleep apnoea.
    Eur Respir J. 2023;61:2202316.
    PubMed    


  19. CORTESE R, Adams TS, Cataldo KH, Hummel J, et al
    Single-cell RNA-seq uncovers cellular heterogeneity and provides a signature for paediatric sleep apnoea.
    Eur Respir J. 2023;61:2201465.
    PubMed     Abstract available


  20. TAMISIER R, Pepin JL, Woehrle H, Salvat M, et al
    Effect of adaptive servo-ventilation for central sleep apnoea in systolic heart failure on muscle sympathetic nerve activity: a SERVE-HF randomised ancillary study.
    Eur Respir J. 2023;61:2200384.
    PubMed     Abstract available


    January 2023
  21. LEVY P, Schiza S
    Are type III devices the future of sleep disordered breathing management?
    Eur Respir J. 2023;61:2201947.
    PubMed    


  22. RIHA RL, Celmina M, Cooper B, Hamutcu-Ersu R, et al
    ERS technical standards for using type III devices (limited channel studies) in the diagnosis of sleep disordered breathing in adults and children.
    Eur Respir J. 2023;61:2200422.
    PubMed     Abstract available


  23. DURGAN DJ, Farre R
    Gut check: assessing the role of the gut microbiota in the adverse cardiovascular effects of obstructive sleep apnoea.
    Eur Respir J. 2023;61:2201974.
    PubMed    


  24. BADRAN M, Khalyfa A, Ericsson AC, Puech C, et al
    Gut microbiota mediate vascular dysfunction in a murine model of sleep apnoea: effect of probiotics.
    Eur Respir J. 2023;61:2200002.
    PubMed     Abstract available


  25. WANG X, Fan J, Guo R, Hao W, et al
    Association of obstructive sleep apnoea with cardiovascular events in women and men with acute coronary syndrome.
    Eur Respir J. 2023;61:2201110.
    PubMed     Abstract available


    July 2022
  26. JUSTEAU G, Gerves-Pinquie C, Jouvenot M, Pigeanne T, et al
    Cancer risk in adherent users of polyurethane foam-containing CPAP devices for sleep apnoea.
    Eur Respir J. 2022;60.
    PubMed    


  27. LECHAT B, Appleton S, Melaku YA, Hansen K, et al
    Comorbid insomnia and sleep apnoea is associated with all-cause mortality.
    Eur Respir J. 2022;60.
    PubMed     Abstract available


    June 2022
  28. PEPIN JL, Eastwood P, Eckert DJ
    Novel avenues to approach non-CPAP therapy and implement comprehensive obstructive sleep apnoea care.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


    May 2022
  29. LEVY P, Naughton MT, Tamisier R, Cowie MR, et al
    Sleep apnoea and heart failure.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


  30. PALM A, Grote L, Ekstrom M, Ljunggren M, et al
    Health risks related to polyurethane foam degradation in CPAP devices used for sleep apnoea treatment.
    Eur Respir J. 2022;59.
    PubMed    


    April 2022
  31. CORTESE R, Sanz-Rubio D, Kheirandish-Gozal L, Marin JM, et al
    Epigenetic age acceleration in obstructive sleep apnoea is reversible with adherent treatment.
    Eur Respir J. 2022;59.
    PubMed    


  32. GAMBINO F, Bonsignore MR
    Can CPAP protect from cancer incidence in obstructive sleep apnoea patients? No evidence yet.
    Eur Respir J. 2022;59.
    PubMed    


  33. MARTINEZ-GARCIA MA, Levy P
    Some forgotten issues in sleep apnoea.
    Eur Respir J. 2022;59.
    PubMed    


  34. OSORIO RS, Martinez-Garcia MA, Rapoport DM
    Sleep apnoea in the elderly: a great challenge for the future.
    Eur Respir J. 2021;59.
    PubMed     Abstract available


  35. JUSTEAU G, Bailly S, Gerves-Pinquie C, Trzepizur W, et al
    Cancer risk in patients with sleep apnoea following adherent 5-year CPAP therapy.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


    February 2022
  36. IP MS, Tse HF, Lam DC, Lui MM, et al
    Reply: High-sensitive cardiac troponin after CPAP in obstructive sleep apnoea.
    Eur Respir J. 2022;59.
    PubMed    


  37. MONNERET D
    High-sensitive cardiac troponin after CPAP in obstructive sleep apnoea: the adjusted analytical change limit (adjACL) for small variations at low concentrations.
    Eur Respir J. 2022;59.
    PubMed    


  38. LIU Y, Yang L, Stampfer MJ, Redline S, et al
    Physical activity, sedentary behaviour and incidence of obstructive sleep apnoea in three prospective US cohorts.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


    November 2021
  39. GAISL T, Turnbull CD, Weimann G, Unger S, et al
    BAY 2253651 for the treatment of obstructive sleep apnoea: a multicentre, double-blind, randomised controlled trial (SANDMAN).
    Eur Respir J. 2021;58.
    PubMed    


    October 2021
  40. FARRE R, Gozal D, Almendros I
    Human experimental models: seeking to enhance multiscale research in sleep apnoea.
    Eur Respir J. 2021;58.
    PubMed    


  41. SCHIZA S, Levy P, Martinez-Garcia MA, Pepin JL, et al
    The search for realistic evidence on the outcomes of obstructive sleep apnoea.
    Eur Respir J. 2021;58.
    PubMed    


  42. WALTZ X, Beaudin AE, Belaidi E, Raneri J, et al
    Impact of obstructive sleep apnoea and intermittent hypoxia on blood rheology: a translational study.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


  43. HARKI O, Tamisier R, Pepin JL, Bailly S, et al
    VE-cadherin cleavage in sleep apnoea: new insights into intermittent hypoxia-related endothelial permeability.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


  44. LUI MM, Tse HF, Lam DC, Lau KK, et al
    Continuous positive airway pressure improves blood pressure and serum cardiovascular biomarkers in obstructive sleep apnoea and hypertension.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


    May 2021
  45. WANG H, Goodman MO, Sofer T, Redline S, et al
    Cutting the fat: advances and challenges in sleep apnoea genetics.
    Eur Respir J. 2021;57.
    PubMed    


  46. DRAGER LF, Martinez-Garcia MA
    Thoracic aortic aneurysms: expanding the potential cardiovascular consequences of obstructive sleep apnoea.
    Eur Respir J. 2021;57.
    PubMed    


  47. STRAUSZ S, Ruotsalainen S, Ollila HM, Karjalainen J, et al
    Genetic analysis of obstructive sleep apnoea discovers a strong association with cardiometabolic health.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  48. GAISL T, Rejmer P, Roeder M, Baumgartner P, et al
    Obstructive sleep apnoea and the progression of thoracic aortic aneurysm: a prospective cohort study.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    March 2021
  49. SCHIZA S, Simonds A, Randerath W, Fanfulla F, et al
    Sleep laboratories reopening and COVID-19: a European perspective.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  50. BLANCHARD M, Gerves-Pinquie C, Feuilloy M, Le Vaillant M, et al
    Hypoxic burden and heart rate variability predict stroke incidence in sleep apnoea.
    Eur Respir J. 2021;57.
    PubMed    


    February 2021
  51. BONSIGNORE MR, Randerath W, Schiza S, Verbraecken J, et al
    European Respiratory Society statement on sleep apnoea, sleepiness and driving risk.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    August 2020
  52. ADIR Y, Humbert M, Chaouat A
    Sleep-related breathing disorders and pulmonary hypertension.
    Eur Respir J. 2020 Aug 3. pii: 13993003.02258-2020.
    PubMed     Abstract available


    May 2020
  53. PENGO MF, Soranna D, Giontella A, Perger E, et al
    Obstructive sleep apnoea treatment and blood pressure: which phenotypes predict a response? A systematic review and meta-analysis.
    Eur Respir J. 2020;55.
    PubMed     Abstract available


    April 2020
  54. PEPIN JL, Martinez-Garcia MA
    Sleep disorders and cerebrovascular disease: the long and winding road.
    Eur Respir J. 2020;55.
    PubMed    


    March 2020
  55. BILLINGS ME, Levy P, Ayas N
    Suboptimal CPAP adherence: half a loaf is better than no bread at all.
    Eur Respir J. 2020;55.
    PubMed    


    May 2019
  56. TAFELMEIER M, Knapp M, Lebek S, Floerchinger B, et al
    Predictors of delirium after cardiac surgery in patients with sleep-disordered breathing.
    Eur Respir J. 2019 May 20. pii: 13993003.00354-2019.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sleep Disorders is free of charge.